Former US FDA Commish Califf Endorses ‘Tortoise’ Approach To Clinical Trials

The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion.